Development of Pulmonary Arterial Hypertension in Women: Interplay of Sex Hormones and Pulmonary Vascular Disease | Zendy

Meredith E. Pugh | Zendy; Anna R. Hemnes | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Development of Pulmonary Arterial Hypertension in Women: Interplay of Sex Hormones and Pulmonary Vascular Disease

Author(s) -

Meredith E. Pugh,

Anna R. Hemnes

Publication year - 2010

Publication title -

women s health

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.363

H-Index - 39

eISSN - 1745-5065

pISSN - 1745-5057

DOI - 10.2217/whe.09.88

Subject(s) - estrogen , disease , hormone , pulmonary hypertension , medicine , dehydroepiandrosterone , physiology , vascular disease , heart disease , pulmonary disease , endocrinology , androgen

Pulmonary arterial hypertension (PAH) is a progressive disease of the pulmonary vasculature, ultimately resulting in right heart failure and death. This disease is strongly predominant in females, although little is known regarding how sex influences disease development. Recent developments highlighting the importance of estrogen metabolites in both animal models and human disease have substantially increased our understanding of PAH in women. This review will focus on general knowledge of PAH, translational and basic science data regarding sex hormones in the pulmonary vasculature and on clinical issues that are particular to women with PAH. Future directions for study include the influence of sex hormones on right ventricular responses, improving the understanding of the influence of estrogen exposure in human disease and the study of dehydroepiandrosterone in basic science and human disease.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research